Clinical Trial Update: NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating NOX-A12 in combination with bendamustine and rituximab for relapsed chronic lymphocy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• NOX-A12
• Rituximab (rituximab)

Snippet

Sponsor: TME Pharma AG | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED